Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
A phase 2 trial of Transcranial focused ultrasound systems in Glioma & glioblastoma, run by Northwestern University, now recruiting.
Overview
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma is a phase 2 interventional study registered as NCT05864534 by Northwestern University, with 25 participants planned, started 2024-01-19 and due to reach its primary completion in 2031-07-31. Interventions recorded: Balstilimab, Botensilimab, Liposomal Doxorubicin, Sonocloud-9 (SC-9). Conditions recorded: Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype, Gliosarcoma, Glioblastoma Multiforme.
Linked to the technology Transcranial focused ultrasound systems because the registry names it ("sonocloud") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialVorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
Shares Balstilimab and the tag pipeline.
- TrialSonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Shares Transcranial focused ultrasound systems (Exablate Neuro, SonoCloud), Glioma & glioblastoma and the tag pipeline.
- TrialBlood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG
Shares Doxorubicin, Glioma & glioblastoma and the tag pipeline.
- TrialBlood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Shares Doxorubicin, Glioma & glioblastoma and the tag pipeline.
- TrialA Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Shares Balstilimab and the tag pipeline.
- TrialInjection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Shares Glioma & glioblastoma and the tag pipeline.